Eric Lawitz, University of Texas Health
These include: Semaglutide A GLP-1 receptor agonist originally used to manage diabetes, Semaglutide is now FDA-approved for chronic weight management under brand names like Wegovy and Ozempic
Ozempic and Wegovy maker sues over compounded, off-brand versions of drugs used for weight loss Novo Nordisk, the pharmaceutical company that makes Ozempic and Wegovy, filed multiple lawsuits Tuesday against off-brand versions of the wildly popular drugs
In this context, our data with nifedipine can be understood
Whether you choose IVIM, another provider, or a direct compounding pharmacy arrangement, having access to reliable, unbiased peptide education makes the entire process more effective and safer